Free tool
FAERS Monitor: Diltiazem Hydrochloride In 0.72% Sodium Chloride
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 218038 or its brand name (Diltiazem Hydrochloride In 0.72% Sodium Chloride, Diltiazem Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
11,574
Serious
9,725
84% of reports
Hospitalization
5,333
Death reported
2,765
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dyspnoea1,345
- pain1,211
- fatigue1,162
- fall1,056
- arthralgia921
- diarrhoea912
- headache904
- dizziness899
- nausea871
- pruritus870
- pyrexia844
- drug ineffective843
- hypotension842
- off label use811
- hypersensitivity748
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 381 |
| 2005 | 388 |
| 2006 | 235 |
| 2007 | 173 |
| 2008 | 185 |
| 2009 | 169 |
| 2010 | 220 |
| 2011 | 192 |
| 2012 | 310 |
| 2013 | 282 |
| 2014 | 210 |
| 2015 | 256 |
| 2016 | 297 |
| 2017 | 311 |
| 2018 | 312 |
| 2019 | 358 |
| 2020 | 519 |
| 2021 | 873 |
| 2022 | 1,421 |
| 2023 | 1,092 |
| 2024 | 1,322 |
| 2025 | 1,294 |
| 2026 | 774 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,585 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| hypotensionSignal | 842 | 7.7 | 7.2 | 4,892 |
| hypersensitivitySignal | 748 | 7.3 | 6.9 | 4,116 |
| fallSignal | 1,056 | 5.8 | 5.5 | 4,224 |
| pyrexiaSignal | 844 | 4.4 | 4.2 | 2,279 |
| dyspnoeaSignal | 1,345 | 4.3 | 4.1 | 3,522 |
| pruritusSignal | 870 | 4.1 | 3.9 | 2,087 |
| arthralgiaSignal | 921 | 4.0 | 3.8 | 2,134 |
| painSignal | 1,211 | 3.6 | 3.4 | 2,321 |
| dizzinessSignal | 899 | 3.3 | 3.1 | 1,454 |
| fatigueSignal | 1,162 | 2.7 | 2.6 | 1,303 |
| headacheSignal | 904 | 2.6 | 2.5 | 932 |
| diarrhoeaSignal | 912 | 2.6 | 2.4 | 899 |
| nauseaSignal | 871 | 2.0 | 1.9 | 452 |
| off label use | 811 | 1.7 | 1.6 | 234 |
| drug ineffective | 843 | 1.2 | 1.1 | 20 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.